Table 4.
The characteristics of living donors
| Parameters | Donors (n = 23) |
| Preoperative | |
| Age (yr) | 37.7 ± 10.2 |
| Gender (male/female) | 8/15 |
| BMI (kg/m2) | 23.8 ± 3.5 |
| Relationship with recipient (n) | |
| Siblings | 12 |
| Daughter | 4 |
| Wives | 5 |
| Father | 1 |
| Uncle | 1 |
| Assessment time (d) | 2.1 ± 1.3 |
| Intraoperative | |
| Graft steatosis (normal/mild) | 18/5 |
| Graft type (right lobe/left lobe) | 20/3 |
| RLV/TLV (%) | 56.5 ± 12.1 |
| Operation time (h) | 6.9 ± 1.4 |
| Blood lost (mL) | 665.2 ± 480.9 |
| Postoperative | |
| Hospital stay (d) | 13.4 ± 3.5 |
| Peak of TB (μmol/L) | 53.4 ± 22.7 |
| Peak of INR | 1.71 ± 0.36 |
| Complications (n) | 11 |
| GradeI(n = 7) | |
| Pleural effusion (mild) | 4 |
| Hepatic function impairment (mild) | 2 |
| Hepatic cut-section local fluid collection | 1 |
| Grade II (n = 3) | |
| Pleural effusion (moderate) leading to partial compression atelectasis and hepatic function impairment (mild) | 1 |
| Pleural effusion (moderate) and pericardial effusion | 1 |
| Pulmonary infection undergone antibiotic therapy and hepatic function impairment (moderate) | 1 |
| Grade IIIa (n = 1) | |
| Pleural effusion (server) using pleurocentesis | 1 |
Hepatic function impairment: Mild, hyperbilirubinemia (TB being 51-85 μmol/L for more than 3 d or 34-51 μmol/L on POD7) and/or PT prolongation (6-8 s for more than 3 d or 4-6 s on POD7); Moderate, hyperbilirubinemia (TB > 85 μmol/L for more than 3 d or exceeding 51 μmol/L on POD7) and/or PT prolongation (> 8 s for more than 3 d or exceeding 6 s on POD7). BMI: Body mass index; RLV: Remanet live volume; TLV: Total liver volume; TB: Total bilirubin; INR: International normalized ratio; PT: Prothrombin time.